A non-chemotherapy treatment of a primary effusion lymphoma: Durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy [1]

Thorvardur R. Halfdanarson, Svetomir Nenad Markovic, U. Kalokhe, M. Luppi

Research output: Contribution to journalArticle

63 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1849-1850
Number of pages2
JournalAnnals of Oncology
Volume17
Issue number12
DOIs
StatePublished - Dec 2006

Fingerprint

HIV Seronegativity
Phosphorous Acids
Primary Effusion Lymphoma
Remission Induction
Immunophenotyping
Combined Modality Therapy
Cytosine
Antineoplastic Agents
Antiviral Agents
Lymphoma
HIV
Drug Therapy
Therapeutics
cidofovir

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

A non-chemotherapy treatment of a primary effusion lymphoma : Durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy [1]. / Halfdanarson, Thorvardur R.; Markovic, Svetomir Nenad; Kalokhe, U.; Luppi, M.

In: Annals of Oncology, Vol. 17, No. 12, 12.2006, p. 1849-1850.

Research output: Contribution to journalArticle

@article{60af60adbfda47b7aaaecde65bce6b18,
title = "A non-chemotherapy treatment of a primary effusion lymphoma: Durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy [1]",
author = "Halfdanarson, {Thorvardur R.} and Markovic, {Svetomir Nenad} and U. Kalokhe and M. Luppi",
year = "2006",
month = "12",
doi = "10.1093/annonc/mdl139",
language = "English (US)",
volume = "17",
pages = "1849--1850",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - A non-chemotherapy treatment of a primary effusion lymphoma

T2 - Durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy [1]

AU - Halfdanarson, Thorvardur R.

AU - Markovic, Svetomir Nenad

AU - Kalokhe, U.

AU - Luppi, M.

PY - 2006/12

Y1 - 2006/12

UR - http://www.scopus.com/inward/record.url?scp=33845353262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845353262&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdl139

DO - 10.1093/annonc/mdl139

M3 - Article

C2 - 16766593

AN - SCOPUS:33845353262

VL - 17

SP - 1849

EP - 1850

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 12

ER -